Related references
Note: Only part of the references are listed.5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease
Nasrin Hashemi-Firouzi et al.
METABOLIC BRAIN DISEASE (2018)
Activation and blockade of basolateral amygdala 5-HT6 receptor produce anxiolytic-like behaviors in an experimental model of Parkinson's disease
Yi-Na Sun et al.
NEUROPHARMACOLOGY (2018)
Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior
Jordan G McCall et al.
eLife (2017)
Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson's disease
Kryspin Andrzejewski et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Anxiolytic effects of prelimbic 5-HT1A receptor activation in the hemiparkinsonian rat
Yan Ping Hui et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats
Kun-Cheng Liu et al.
NEUROPHARMACOLOGY (2015)
Activation of 5-HT1A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease
Yi-Na Sun et al.
NEUROPHARMACOLOGY (2015)
Activation of serotonin2A receptors in the medial septum-diagonal band of Broca complex enhanced working memory in the hemiparkinsonian rats
Li-Bo Li et al.
NEUROPHARMACOLOGY (2015)
ACTIVATION AND BLOCKADE OF SEROTONIN7 RECEPTORS IN THE PRELIMBIC CORTEX REGULATE DEPRESSIVE-LIKE BEHAVIORS IN A 6-HYDROXYDOPAMINE-INDUCED PARKINSON'S DISEASE RAT MODEL
Q. J. Zhang et al.
NEUROSCIENCE (2015)
Early Adolescent MK-801 Exposure Impairs the Maturation of Ventral Hippocampal Control of Basolateral Amygdala Drive in the Adult Prefrontal Cortex
Daniel R. Thomases et al.
JOURNAL OF NEUROSCIENCE (2014)
HIPPOCAMPAL UCP2 IS ESSENTIAL FOR COGNITION AND RESISTANCE TO ANXIETY BUT NOT REQUIRED FOR THE BENEFITS OF EXERCISE
D. Wang et al.
NEUROSCIENCE (2014)
Local infusion of citalopram into the basolateral amygdala decreased conditioned fear of rats through increasing extracellular serotonin levels
Yuji Kitaichi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits
Miguel M. Carvalho et al.
MOLECULAR NEURODEGENERATION (2013)
Distinct contributions of human hippocampal theta to spatial cognition and anxiety
Brian R. Cornwell et al.
HIPPOCAMPUS (2012)
Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism
Claire Delaville et al.
NEUROBIOLOGY OF DISEASE (2012)
L-DOPA-INDUCED DYSREGULATION OF EXTRASTRIATAL DOPAMINE AND SEROTONIN AND AFFECTIVE SYMPTOMS IN A BILATERAL RAT MODEL OF PARKINSON'S DISEASE
K. L. Eskow Jaunarajs et al.
NEUROSCIENCE (2012)
The Serotonin-6 Receptor as a Novel Therapeutic Target
Hyung-Mun Yun et al.
Experimental Neurobiology (2012)
Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats
Julia Jungnickel et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats
Li Chen et al.
BRAIN RESEARCH BULLETIN (2011)
Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions
Li Chen et al.
BRAIN RESEARCH BULLETIN (2011)
The serotonergic system in Parkinson's disease
Philippe Huot et al.
PROGRESS IN NEUROBIOLOGY (2011)
Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats
Gregory V. Carr et al.
PSYCHOPHARMACOLOGY (2011)
The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration
Agnieszka Nikiforuk et al.
PSYCHOPHARMACOLOGY (2011)
Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat
Karen L. Eskow Jaunarajs et al.
BEHAVIOURAL PHARMACOLOGY (2010)
Adolescent Male Rats Exposed to Social Defeat Exhibit Altered Anxiety Behavior and Limbic Monoamines as Adults
Michael J. Watt et al.
BEHAVIORAL NEUROSCIENCE (2009)
In vivo effects of activation and blockade of 5-HT2A/2C receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease
Shuang Wang et al.
EXPERIMENTAL NEUROLOGY (2009)
ACTIVATION OF THE 5-HT6 RECEPTOR ATTENUATES LONG-TERM POTENTIATION AND FACILITATES GABAergic NEUROTRANSMISSION IN RAT HIPPOCAMPUS
P. J. West et al.
NEUROSCIENCE (2009)
The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885:: The impact of benzodiazepine receptors
Anna Wesolowska
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model
Igor Branchi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
EMOTIONAL, COGNITIVE AND NEUROCHEMICAL ALTERATIONS IN A PREMOTOR STAGE MODEL OF PARKINSON'S DISEASE
M. T. Tadaiesky et al.
NEUROSCIENCE (2008)
Neuropharmacological profile of novel and selective 5-HT6 receptor agonists:: WAY-181187 and WAY-208466
Lee E. Schechter et al.
NEUROPSYCHOPHARMACOLOGY (2008)
The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram
Wei-Li Kuan et al.
PSYCHOPHARMACOLOGY (2008)
Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats
Anna Wesolowska et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression
Anna Wesolowska et al.
NEUROPHARMACOLOGY (2007)
The role of hippocampus in anxiety: intracerebral infusion studies
Elif Engin et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data
B Scholtissen et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
The selective GABA Reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: Results of a placebo-controlled study
MH Pollack et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
State-dependent alterations in hippocampal oscillations in serotonin 1A receptor-deficient mice
JA Gordon et al.
JOURNAL OF NEUROSCIENCE (2005)
5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex
LP Lacroix et al.
SYNAPSE (2004)
5-ht(6) Receptors
Marie L. Woolley et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2004)
Regional dissociations within the hippocampus - memory and anxiety
DM Bannerman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
Reduced fear expression after lesions of the ventral hippocampus
KG Kjelstrup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Behavioral profile of wild mice in the elevated plus-maze test for anxiety
A Holmes et al.
PHYSIOLOGY & BEHAVIOR (2000)
Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat
LM Broersen et al.
PSYCHOPHARMACOLOGY (2000)
The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain
H Kawahara et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
